BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28592125)

  • 1. Correlation of Gankyrin oncoprotein overexpression with histopathological grade in prostate cancer.
    Riahi MM; Sistani NS; Zamani P; Abnous K; Jamialahmadi K
    Neoplasma; 2017; 64(5):732-737. PubMed ID: 28592125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.
    Wang C; Li Y; Chu CM; Zhang XM; Ma J; Huang H; Wang YN; Hong TY; Zhang J; Pan XW; Zheng JC; Jiang N; Hu CY; Ma X; Sun YH; Cui XG
    EBioMedicine; 2019 Jan; 39():255-264. PubMed ID: 30558998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
    Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression.
    Kim YH; Kim JH; Choi YW; Lim SK; Yim H; Kang SY; Chung YS; Lee GY; Park TJ
    Exp Mol Pathol; 2013 Apr; 94(2):360-5. PubMed ID: 23276718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor.
    Ando S; Matsuoka T; Kawai K; Sugita S; Joraku A; Kojima T; Suetomi T; Miyazaki J; Fujita J; Nishiyama H
    Int J Urol; 2014 Oct; 21(10):992-8. PubMed ID: 24861729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gankyrin: a new oncoprotein and regulator of pRb and p53.
    Dawson S; Higashitsuji H; Wilkinson AJ; Fujita J; Mayer RJ
    Trends Cell Biol; 2006 May; 16(5):229-33. PubMed ID: 16581249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance.
    Jing H; Zhang G; Meng L; Meng Q; Mo H; Tai Y
    Sci Rep; 2014 Jul; 4():5503. PubMed ID: 24999092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation.
    Higashitsuji H; Liu Y; Mayer RJ; Fujita J
    Cell Cycle; 2005 Oct; 4(10):1335-7. PubMed ID: 16177571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected Lower Expression of Oncoprotein Gankyrin in Drug Resistant ABCG2 Overexpressing Breast Cancer Cell Lines.
    Taheri T; Jamialahmadi K; Khadijeh F
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3413-3418. PubMed ID: 29286612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway.
    Wang WP; Sun Y; Lu Q; Zhao JB; Wang XJ; Chen Z; Ni YF; Wang JZ; Han Y; Zhang ZP; Yan XL; Li XF
    Oncotarget; 2017 Jan; 8(4):5909-5923. PubMed ID: 27992365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer.
    Tang S; Yang G; Meng Y; Du R; Li X; Fan R; Zhao L; Bi Q; Jin J; Gao L; Zhang L; Li H; Fan M; Wang Y; Wu K; Liu J; Fan D
    Cancer Biol Ther; 2010 Jan; 9(2):88-95. PubMed ID: 19901563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gankyrin, a biomarker for epithelial carcinogenesis, is overexpressed in human oral cancer.
    Li J; Knobloch TJ; Kresty LA; Zhang Z; Lang JC; Schuller DE; Weghorst CM
    Anticancer Res; 2011 Sep; 31(9):2683-92. PubMed ID: 21868508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3.
    Sakurai T; Higashitsuji H; Kashida H; Watanabe T; Komeda Y; Nagai T; Hagiwara S; Kitano M; Nishida N; Abe T; Kiyonari H; Itoh K; Fujita J; Kudo M
    Oncotarget; 2017 Apr; 8(15):24762-24776. PubMed ID: 28160571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of human oncoprotein gankyrin in Zebrafish.
    Kim SY; Hur W; Choi JE; Kim D; Wang JS; Yoon HY; Piao LS; Yoon SK
    Exp Mol Med; 2009 Jan; 41(1):8-16. PubMed ID: 19287195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gankyrin promotes the proliferation of human pancreatic cancer.
    Meng Y; He L; Guo X; Tang S; Zhao X; Du R; Jin J; Bi Q; Li H; Nie Y; Liu J; Fan D
    Cancer Lett; 2010 Nov; 297(1):9-17. PubMed ID: 20483533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma.
    Umemura A; Itoh Y; Itoh K; Yamaguchi K; Nakajima T; Higashitsuji H; Onoue H; Fukumoto M; Okanoue T; Fujita J
    Hepatology; 2008 Feb; 47(2):493-502. PubMed ID: 18161051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gankyrin is frequently overexpressed in cervical high grade disease and is associated with cervical carcinogenesis and metastasis.
    Liu Y; Zhang J; Qian W; Dong Y; Yang Y; Liu Z; Feng Y; Ma D; Zhang Z; Wu S
    PLoS One; 2014; 9(4):e95043. PubMed ID: 24751719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.
    Chen J; Bai M; Ning C; Xie B; Zhang J; Liao H; Xiong J; Tao X; Yan D; Xi X; Chen X; Yu Y; Bast RC; Zhang Z; Feng Y; Zheng W
    Oncogene; 2016 May; 35(19):2506-17. PubMed ID: 26364616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.